Yang Jiayi, Zhang Wei, Lin Binghao, Mao Shuming, Liu Guangyao, Tan Kai, Tang Jiahao
Department of Obstetrics and Gynecology, The First Affiliated Hospital Hospital of Wenzhou Medical University, Nanbaixiang Street, Ouhai District, Wenzhou 325000, Zhejiang Province, People's Republic of China.
Department of Orthopaedics Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, NO.109, Xueyuan West Road, Lucheng District, Wenzhou 325000, Zhejiang Province, People's Republic of China.
ACS Omega. 2024 Jun 28;9(27):29544-29556. doi: 10.1021/acsomega.4c02322. eCollection 2024 Jul 9.
This study examined the surface modification of titanium (Ti) implants to enhance early-stage osseointegration, which reduced the failure rate of internal fixation in osteoporotic fractures that inherently decrease in bone mass and strength. We employed a layer-by-layer electroassembly technique to deposit catalpol-containing hyaluronic acid/chitosan multilayers onto the surface of Ti implants. To evaluate the in vitro osteoinductive effects of catalpol-coated Ti implants, the robust osteoblast differentiation capacity of the murine preosteoblast cell line, MC3T3-E1, was employed. Furthermore, the performance of these implants was evaluated in vivo through femoral intramedullary implantation in Sprague-Dawley rats. The engineered implant effectively regulated catalpol release, promoting increased bone formation during the initial stages of implantation. The in vitro findings demonstrated that catalpol-coated Ti surfaces boosted ALP activity, cell proliferation as measured by CCK-8, and osteogenic protein expression via WB analysis, surpassing the uncoated Ti group ( < 0.05). In vivo micro-computed tomography (CT) and histological analyses revealed that catalpol-coated Ti significantly facilitated the formation and remodeling of new bone in osteoporotic rats at 14 days post-implantation. This study outlines a comprehensive and straightforward methodology for the fabrication of biofunctional Ti implants to address osteoporosis.
本研究考察了钛(Ti)植入物的表面改性以增强早期骨整合,这降低了骨质疏松性骨折内固定的失败率,骨质疏松性骨折的骨量和强度会固有地降低。我们采用逐层电组装技术将含梓醇的透明质酸/壳聚糖多层膜沉积到Ti植入物表面。为了评估梓醇涂层Ti植入物的体外成骨诱导作用,使用了小鼠前成骨细胞系MC3T3-E1强大的成骨细胞分化能力。此外,通过在Sprague-Dawley大鼠中进行股骨髓内植入,在体内评估了这些植入物的性能。工程化植入物有效地调节了梓醇的释放,促进了植入初期骨形成的增加。体外研究结果表明,梓醇涂层的Ti表面提高了碱性磷酸酶(ALP)活性、通过CCK-8测定的细胞增殖以及通过蛋白质免疫印迹(WB)分析的成骨蛋白表达,超过了未涂层的Ti组(P<0.05)。体内微型计算机断层扫描(CT)和组织学分析显示,梓醇涂层的Ti在植入后14天时显著促进了骨质疏松大鼠新骨的形成和重塑。本研究概述了一种全面且简便的制备生物功能化Ti植入物以解决骨质疏松问题的方法。